ABSTRACT Background: A moderate association exists between body mass index (BMI) and colorectal cancer. Less is known about the effect of weight change. Objective: We investigated the relation between BMI and weight change and subsequent colon and rectal cancer risk. Design: This was studied among 328,781 participants in the prospective European Prospective Investigation into Cancer-Physical Activity, Nutrition, Alcohol, Cessation of Smoking, Eating study (mean age: 50 y). Body weight was assessed at recruitment and on average 5 y later. Self-reported weight change (kg/y) was categorized in sex-specific quintiles, with quintiles 2 and 3 combined as the reference category (men: 20.6 to 0.3 kg/y; women: 20.4 to 0.4 kg/y). In the subsequent years, participants were followed for the occurrence of colon and rectal cancer (median period: 6.8 y). Multivariable Cox proportional hazards regression analyses were used to study the association. Results: A total of 1261 incident colon cancer and 747 rectal cancer cases were identified. BMI at recruitment was statistically significantly associated with colon cancer risk in men (HR: 1.04; 95% CI: 1.02, 1.07). Moderate weight gain (quintile 4) in men increased risk further (HR: 1.32; 95% CI: 1.04, 1.68), but this relation did not show a clear trend. In women, BMI or weight gain was not related to subsequent risk of colon cancer. No statistically significant associations for weight loss and colon cancer or for BMI and weight changes and rectal cancer were found. Conclusions: BMI attained at adulthood was associated with colon cancer risk. Subsequent weight gain or loss was not related to colon or rectal cancer risk in men or women.
INTRODUCTION
Colorectal cancer is the third most common type of cancer worldwide. In 2008, approximately one million cases were reported. It is the fourth most common cause of death from cancer (1) (2) (3) . There is a moderate but consistently reported association between general obesity (as determined by BMI) and colorectal cancer incidence. The RR associated with obesity is more consistent for colon cancer than for rectal cancer and is higher in men than in women (1, 4, 5) .
However, less is known about the effect of weight change on colon or rectal cancer risk. Most studies to date have assessed the effect of weight change since recalled weight at age 18 y (6-11 y). They generally show an increased colon cancer risk in participants with weight gain, but no effect on rectal cancer (6-9) and no effect of weight loss (10) .
Studying effects of weight change later in adulthood, rather than between age 18 and 50 y, may be particularly relevant for public health policies and cancer prevention interventions aimed at middle-aged or older adults who may change their eating and physical activity habits to reduce their risk of developing colon or rectal cancer.
Weight change over shorter periods later in life has been investigated in only a few cohort studies with inconsistent results (12) (13) (14) (15) . In male US health professionals, they found an increased risk of weight gain later in life on colon cancer (12) , whereas no association was found in males from Austria (13) , Sweden (14) , or Norway (15) . Two of these studies also included women and reported no relation (13, 15) .
Effects of weight change may depend on the baseline weight of individuals. Weight gain may be more hazardous if persons are already obese (6) . Furthermore, the timing of the weight change might be relevant. Some studies have indicated that the effect of weight gain is stronger in younger individuals (6) , whereas others indicate that weight gain later in life is an important risk factor for colon cancer (12) .
The aim of the current study was to examine the association between BMI and colon and rectal cancer and the effect of subsequent weight change later in life in men and women. We investigated this in the European Prospective Investigation into Cancer-Physical Activity, Nutrition, Alcohol, Cessation of Smoking, Eating out of home And obesity (EPIC-PANACEA) study-a subset of the total EPIC cohort-with .300,000 participants aged on average w50 y at recruitment and with a repeated prospective assessment of anthropometric measures (16) .
SUBJECTS AND METHODS

Subjects
The EPIC-PANACEA study, which is a part of EPIC with repeated anthropometric data available, is originally designed to investigate the determinants of obesity and weight changes in Europe (16) .
The EPIC study is an ongoing multicenter prospective cohort study, designed to investigate the relation of nutrition and lifestyle with cancer and other chronic diseases (17, 18) . In EPIC, .520,000 men and women aged between 25 and 70 y were recruited between 1992 and 2000 from 23 centers in 10 countries (Denmark, France, Germany, Greece, Italy, the Netherlands, Norway, Spain, Sweden, and the United Kingdom). In most centers, participants were invited from the general population residing in a given town or geographical area, except for France, where members of the health insurance for teachers were included; a large part of the Spanish and Italian centers included blood donors, and the cohorts in Utrecht and Florence included women attending the breast cancer screening program. Half of the participants recruited by the Oxford center are "health-conscious" vegetarian or healthy eaters. In France, Norway, Utrecht, and Naples (Italy), only women were recruited. Therefore, w75% of the EPIC population is female. All participants provided written informed consent. Approval for the EPIC study was obtained from the ethical review board of the International Agency for Research on Cancer in addition to ethical approvals from the local center.
For EPIC-PANACEA, 167,008 participants were excluded according to the PANACEA exclusion criteria, ie, missing dietary and nondietary questionnaires, extreme energy intake to energy expenditure ratio, pregnant women, missing weight at recruitment or extreme anthropometric values [ie, height ,1.3 m, BMI (in kg/m 2 ) ,16, waist circumference .160 cm, and waist circumference ,60 cm in combination with BMI .25), missing follow-up weight (this included the cohorts of Turin and Ragusa (both Italy), and parts of cohorts from Norway and Naples (Italy)], or participants with a weight change of #5 or .5 kg/y over several years (16, 19) . For our study, we further excluded participants with prevalent cancer at recruitment (n = 16,493) and participants with cancer before the second weight assessment (n = 9166); therefore, 328,781 participants (91,231 men and 237,550 women) remained.
Anthropometric measurements
Anthropometric measures were assessed twice; the first assessment was at recruitment, the second on average 5 y later. During the first assessment, anthropometric measures were made in all centers except for Oxford (United Kingdom), Norway, and France, where anthropometric data were self-reported. The second assessment for anthropometric measures was by selfreport, except for participants in Cambridge (United Kingdom) and Doetinchem (Netherlands), where weight was measured. Body weight and height were measured by using standardized procedures. Weight was measured to the nearest 0.1 kg, and height was measured to the nearest 0.1, 0.5, or 1.0 cm depending on the study center while the subjects were shoeless. Weight measurements were corrected to account for protocol differences between centers because of different procedures used to measure height and weight; ie, for subjects who were normally dressed and without shoes, 1.5 kg for weight was subtracted from the original measurement, whereas 1 kg was subtracted for subjects in light clothing without shoes (20) .
Weight change was defined as weight at the second assessment minus weight at the first assessment divided by the number of years between weight assessments, because follow-up times between the first and second weight assessments differed by center (2-11 y). Waist circumference was measured at recruitment and was reassessed only at a few centers. We therefore were not able to study waist changes in relation to colon and rectal cancer risk.
Assessment of confounders
At recruitment, detailed country-specific dietary questionnaires and standardized detailed questionnaires about lifestyle and medical history were assessed, including questions on education, medical history, smoking history, alcohol consumption, physical activity, and, for women, reproductive and menstrual history and use of exogenous hormone therapy (hormone replacement therapy and oral contraceptives) and menopausal status (18) .
Assessment of endpoints
In EPIC, participants were followed for the occurrence of colon and rectal cancer from recruitment onward. In the current study, we were interested in colon and rectal cancers occurring after the second weight assessment (Figure 1) . Hence, participants were followed for the occurrence of colon and rectal cancer after the second weight assessment until other cancer diagnosis (except nonmelanoma skin cancer), death, emigration, or the end of the follow-up period occurred, whichever came first.
Colon cancers were defined as tumors in the cecum, appendix, ascending colon, hepatic flexure, transverse colon, splenic flexure, and descending and sigmoid colon (C18.0-C18.7); rectal cancers included tumors in the recto-sigmoid junction (C19) or rectum (C20), following the 10th Revision of the International Statistical Classification of Diseases, Injury and Causes of Death). Anal canal cancers were excluded.
Incident colon and rectal cancer cases were identified through linkage to cancer registry data (Denmark, Italy, Netherlands, Norway, Spain, Sweden, and the United Kingdom). In France, Germany, and Greece, a combination of methods is used including health insurance records, cancer and pathology registries, and contacts with study participants and their next-of-kin. Mortality data were obtained from mortality registries at the regional or national level. Cancer cases were identified by the end of the censoring periods ending between December 2004 and December 2008, depending on the most recent linkage of a center's database with the respective cancer registry. For Germany and Greece, the end of the follow-up was the last known contact, date of diagnosis, or date of death, whichever came first.
Data analysis
HRs for colon and rectal cancer incidence were calculated by using Cox proportional hazards regression models, stratified by center to account for differences in questionnaire designs, follow-up procedures, and other center-specific effects. Additional stratification by age at recruitment (1-y categories) was used. The time at entry was the age at second weight assessment, whereas the exit time was the age at cancer diagnosis, death, loss, or end of follow-up, whichever came first.
First, the relation between BMI at recruitment and colon and rectal cancer was investigated. An association between body size and risk of colon and rectal cancer was previously reported in the total EPIC cohort (5). Because the EPIC-PANACEA study is a subset of the EPIC study, the associations between BMI at recruitment and risk of colon and rectal cancer were reassessed here for clarity and comparison. In the current analysis in EPIC-PANACEA, survival started from the second weight assessment onward, on average 5 y from recruitment with a range of 2 to 11 y. Hence, it is a selection of EPIC participants that survived this period and did not develop cancer within this period.
Subjects with a BMI ,25.0 were defined as the reference category, those with a BMI between 25.0 and 30.0 were considered overweight, and those with a BMI .30.0 were considered obese (21) . Furthermore, we modeled BMI as a continuous variable.
Second, the association between weight change and colon and rectal cancer was examined. Annual weight change (kg/y) was categorized into sex-specific quintiles, with quintiles 2 and 3 combined as the reference category, defined as those with stable weight (ie, annual weight change of 20.6 to 0.3 kg in men and 20.4 to 0.4 kg in women). In the current literature, no standard criteria of stable weight are available, but a weight change of 62 kg over w5 y has been used as reference before (15 Sex-specific models are presented stratified by age and center (model 1); model 1 plus adjustment for smoking status and intensity (never, former, or quit #10 y ago; former and quit 11-20 y ago; former and quit .20 y ago; current and 1-15 cigarettes/d; current and 16-25 cigarettes/d; current and .26 cigarettes/d; current and pipe/cigar smoking; current or former is missing; or unknown), education (none, primary school, technology school, secondary school, or longer education), alcohol use (yes or no), alcohol intake (g/d), BMI at recruitment, total dietary fiber (g/d) intake, consumption of fruit and vegetables (g/d), fish and shellfish (g/d), red and processed meat (g/d), and time between 2 weight assessments (y) (model 2). For women, additional correction for menopausal status (premenopausal, perimenopausal, postmenopausal, or surgical postmenopausal), use of oral contraceptives (never, former, or current), and use of hormone replacement therapy (never, former, or current) was done (model 3).
Although colon cancer is related to physical activity (22), we did not adjust for physical activity in the current analyses because data were not available at all centers, and physical activity did not affect the effect estimates in the centers where it was available. Tests for linear trend (P-trend) were performed by using the medians across the annual weight change categories (sex-specific quintiles), modeled continuously.
We repeated the analyses for annual weight change as a continuous variable (kg/y) and also for absolute categories of weight change between the first and second assessments: less than 22.0 kg defined as weight loss, between $ 22.0 kg and ,2.0 kg as stable weight, between $2.0 kg and ,5.0 kg as moderate weight gain, $5.0 and ,10.0 kg as moderate-high weight gain, and $10.0 kg as high weight gain.
Heterogeneity of the association according to cancer subtype was assessed by using a data-augmentation method described by Lunn and McNeil (23) . We used a log likelihood ratio test to compare the model with and without interaction terms between BMI and cancer subtype (colon compared with rectal cancer) and also between annual weight change and cancer subtype (colon compared with rectal cancer).
Potential effect modification of the relation between weight change (sex-specific quintiles) and risk of colon and rectal cancer by BMI at recruitment (,25 and $25), age (,60 and $60 y of age at recruitment), and hormone replacement therapy use (never, past, or current; in postmenopausal women only) was explored by using a log likelihood ratio test to compare the model with and without interaction terms.
Additional sensitivity analyses were performed in which we excluded persons with a follow-up for cancer ,2 y after the second weight assessment to reduce the chance of reverse causality by preclinical disease that may lead to weight loss. Furthermore, we performed sensitivity analyses by additionally excluding persons with self-reported chronic diseases at recruitment (heart disease, stroke, and diabetes mellitus). We also performed analyses in never smokers only, to exclude the possibility of (residual) confounding by smoking. Moreover, sensitivity analyses were performed in which we separated the colon into proximal and distal colon. Finally, we performed competing risk analyses [by using Fine and Gray models (24) with death as competing risk] to validate the results of the Cox model.
Missing covariate information (missing: BMI 0.0005%; education 0.03%, oral contraceptives 0.03%, hormone replacement therapy 0.05%) was accounted for by multiple imputation (m = 5). Analyses were performed by using R Studio version 0.97.248 (R studio).
RESULTS
A total of 91,231 men and 237,550 women with a median age of 52.6 and 51.2 y, respectively, were included in the current analysis. Of them, 1261 developed colon cancer (480 men and 781 women) and 747 rectal cancer (354 men and 393 women) during a follow-up of 2.1 million person-years (median: 6.8 y).
Men and women with high weight gain (quintile 5) were younger at recruitment, had lower weight, consumed less fruit and vegetables and alcohol, and were more frequently current smokers than were those with moderate weight gain (quintile 4), stable weight (quintile 2 + quintile 3), or weight loss (quintile 1) ( Table 1) .
BMI at recruitment was associated with an increased risk of colon cancer in men (per 1-kg/m 2 higher BMI: HR: 1.04; 95% CI: 1.02, 1.07) and with a marginally statistically significantly increased risk in women (HR: 1.02; 95% CI: 1.00, 1.04) ( Table  2) . Compared with normal weight, obese men had a higher risk of colon cancer (HR: 1.49; 95% CI: 1.13, 1.97) and women had a tendency toward an increased risk (HR: 1.24; 95% CI: 0.99, 1.56). No significant associations were found for rectal cancer, but tests for heterogeneity did not indicate differences between associations for colon and rectal cancer (men: P = 0.37; women: P = 0.96).
In comparison with stable weight, men with moderate weight gain (quintile 4) had a higher risk of colon cancer (HR: 1.32; 95% CI: 1.04, 1.68), but no effect was seen for high weight gain or weight loss. No associations were found between weight change and rectal cancer in men. In women, no association was found between weight change and risk of colon cancer or rectal cancer. No linear trend across weight-change categories was seen for colon or rectal cancer in men or women (P-trend for all .0.05).
( Table 3 ). The P value for heterogeneity between associations for colon and rectal cancer was not significant (men: P = 0.50; women: P = 0.58). When annual weight change was analyzed as a continuous variable, or when absolute categories of weight change were used, results were comparable and no significant associations between weight change and colon and rectal cancer were found in men or women (see Supplemental Table 1 under "Supplemental data" in the online issue).
The association between weight change (sex-specific quintiles) and colon or rectal cancer was not modified by BMI at recruitment: colon cancer (men: P-interaction = 0.13; women: P-interaction = 0.59) and rectal cancer (men: P-interaction = 0.49; women: P-interaction = 0.47). The interaction between age at recruitment and weight change was also not statistically significant: colon cancer (men: P-interaction = 0.27; women: P-interaction = 0.49) and rectal cancer (men: P-interaction = 0.16; women: P-interaction = 0.17). In postmenopausal women, no interaction was found between hormone replacement therapy and weight change: colon cancer (P-interaction = 0.09) and rectal cancer (P-interaction = 0.99). Stratified analysis showed approximately the same results in different strata (see Supplemental Tables 2-4 under "Supplemental data" in the online issue).
A sensitivity analysis in which we excluded persons with a follow-up ,2 y after the weight change showed that the results remained virtually the same, except that women with high weight gain had a borderline increased risk of rectal cancer (HR: 1.38; 95% CI: 1.00, 1.90). Additional correction for presence of chronic diseases at recruitment and analyses only including never smokers showed approximately the same results (see Supplemental Tables 5 and 6 under "Supplemental data" in the online issue). Sensitivity analyses in which we separated the colon into proximal and distal colon showed comparable results (data not shown). Finally, use of a competing risk analysis instead of a Cox proportional hazards regression analysis showed virtually the same results (data not shown).
DISCUSSION
In our study population of men and women with an average age of .50 y, we found that attained BMI in adulthood was significantly related to colon cancer risk. Associations of similar size, although not statically significant, were found for rectal cancer risk. Subsequent weight gain or loss later in life was not related to colon or rectal cancer risk in men or women, with the exception that only moderate gain increased the risk in men of colon cancer.
The association between BMI and risk of colon and rectal cancer was previously reported in the total EPIC cohort, showing comparable results. They found associations between a higher BMI and an increased risk of colon cancer in men and a tendency toward an increased risk in women [per 1-kg/m 2 higher BMI: men (HR: 1.05; 95% CI: 1.02, 1.08) and women (HR: 1.02; 95% CI: 1.00, 1.04)]. No associations were observed for rectal cancer in men or women (5).
Our results do not indicate a strong effect for weight gain later in life. Two other studies reported comparable results. Rapp et al (13) and Samanic et al (14) found no association between weight gain (assessed prospectively over 6 and 7 y, respectively) and the risk of colon or rectal cancer in men. Another study found, only in overweight men (BMI .25), an increased risk of colon cancer for weight gain of .10 kg over a mean period of 9.6 y (HR: 2.09; 95% CI: 1.21, 3.63), although formal testing did not show that BMI modified the effect of weight change on colon cancer risk (P-interaction = 0.16) (15). In our study, we found no evidence that high weight gain was associated with increased colon cancer risk in men with a BMI .25. In contrast with our results, the Health Professionals Follow-Up Study found a moderately increased colon cancer risk 2-4 y after a 10-lb (4.45-kg) weight gain in 2 y (HR: 1.14; 95% CI: 1.00, 1.29) (12) . This difference might be explained by a larger weight gain (4.45 kg/2 y compared with 1.4 kg/5 y in our study). Two studies also included women and found no increased risk of weight gain in adulthood (13, 15) .
In addition, in line with our findings, most studies did not find an effect of weight loss on colon or rectal cancer risk in men (12) , or in men and women (15) . Only one study found a decrease in colon cancer risk after weight loss (,0.1 kg/m 2 per year) in men (HR: 0.50; 95% CI: 0.29, 0.87), but they did not find evidence of a dose-response relation (13) .
One potential conclusion for colon and rectal cancer risk and weight gain could be that gaining weight later in life is less hazardous than gaining weight earlier in life (after age 18 y). This was also suggested by Renehan et al (6) , who studied weight gain at different ages and showed that the increased risk of weight gain on colon cancer occurs especially in relation to weight gain in early adulthood, between 18 and 35 y per 0.5-kg/y increase for men (HR: 1.18; 95% CI: 1.11, 1.25) and for women (HR: 1.14; 95% CI: 1.02, 1.28).
Our findings could also be explained by the fact that we did not study change in intraabdominal fat but rather change in body weight, which might be a change in total body fat, intraabdominal fat, or even lean body mass. As previously shown in the total EPIC cohort, high amounts of intraabdominal fat (determined by waist circumference or waist-to-hip ratio) were strongly associated with colon cancer risk in both men and women (5) . Abdominal adiposity more than general adiposity seems to be an important risk factor for colon cancer (4, 5) . In the current study, we were not able to distinguish between change in total body fat or change in visceral abdominal fat, because a second waist assessment was unavailable in most EPIC centers. Future studies are needed to investigate the effect of change in abdominal adiposity specifically.
Note that for most of the EPIC-PANACEA participants, the second weight assessment was self-reported. Persons with high BMI are underreporting their weight on average to a larger extent than are persons with normal weight (25) . Thus, results may be biased as a result of misclassification of the second weight assessment. However, a previous study in another subset of EPIC showed that correction of data by using prediction models (obtained from subsets for whom both measured and reported weight was available) did not improve validity (25) .
Another limitation was that weight change was based on 2 measurements only, and we were not able to quantify weight after the second weight assessment. Participants could have experienced fluctuations in weight (yo-yo effect), which we could not take into account.
Furthermore, it was recently suggested that colon cancer is not a homogeneous disease, and evidence is emerging that associations between risk factors and cancer risk depend on bowel subsides (ie, proximal or distal colon), probably because of different molecular carcinogenic pathways (26) (27) (28) . For BMI, a recent meta-analysis suggested that estimates for the association between BMI risk and risk of proximal or distal colon cancer were comparable (29) . In our sensitivity analyses, in which we separated the colon into proximal and distal colon, we showed comparable results for the relation with weight gain.
Increasing evidence indicates that the colon compared with rectal model, or even a 2-colon (proximal compared with distal) model, is not sufficient to investigate risk factors for cancer in the 2 Stratified by center and age at second weight assessment. 3 Additional correction for smoking status and intensity (never, former, or quit #10 y ago; former and quit 11-20 y ago; former and quit .20 y ago; current and 1-15 cigarettes/d; current and 16-25 cigarettes/d; current and .26 cigarettes/d; current and pipe/cigar smoking; current or former is missing; or unknown), education (none, primary school, technology school, secondary school, or longer education), alcohol user (yes or no), alcohol intake (g/d), time between 2 weight assessments (y), total dietary fiber (g/d), fruit and vegetables (g/d), fish and shellfish (g/d), and red and processed meat (g/d). 4 Additional correction for menopausal status (premenopausal, perimenopausal, postmenopausal, or surgical postmenopausal), ever use of oral contraceptives (never, former, or current), or ever use of hormone replacement therapy (never, former, or current) (in women only).
TABLE 3
HRs (and 95% CIs) for colon and rectal cancer in relation to annual weight change (in quintiles) in men and women Stratified by center and age at second weight assessment. Additional correction for menopausal status (premenopausal, perimenopausal, postmenopausal, or surgical postmenopausal), ever use of oral contraceptives (never, former, or current), or ever use of hormone replacement therapy (never, former, or current) (in women only).
bowel (27, 28) . A multisegmental approach will do more justice to the linearity in the frequencies of tumor molecular characteristics, but also requires a much larger sample size than we used here. Another weakness of this study was the lack of tumor molecular data. Unfortunately, although molecular testing is now routine clinical practice, it was not routine yet during the time of diagnosis in this study. Finally, we did not have information to distinguish between intentional and unintentional weight loss. Because (unintentional) weight loss is an important clinical feature of colon cancer (30) , reverse causation might be a potential concern. However, we did not find an effect for weight loss, even when we limited the influence of preexisting disease by lagging follow-up time by 2 y. Furthermore, Parker and Folsom (10) studied the effect of both intentional and unintentional weight loss episodes of .20 lb during adulthood and found no effect on colon cancer: intentional weight loss (HR: 0.91; 95% CI: 0.66, 1.24) and unintentional weight loss (HR: 1.06; 95% CI: 0.80, 1.40). The strengths of the current study included its prospective design, large sample size, large number of incident cancer cases, and detailed information about potential confounders. In conclusion, BMI attained at adulthood was associated with colon cancer risk. Subsequent weight gain or loss was not related to colon or rectal cancer risk in men or women.
